In silico design of a multi-epitope vaccine candidate against SARS-CoV-۲

سال انتشار: 1400
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 128

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

IBIS10_225

تاریخ نمایه سازی: 5 تیر 1401

چکیده مقاله:

Frequent and sometimes more dangerous mutations in the SARS-CoV-۲ indicate that a stronger strategy isneeded to produce an effective vaccine. A vaccine that contains a wider range of virus factors and remainseffective if one or more mutations is happen in a part of the genome. In this study, four important virusproteins, S, E, M and Mpro were used to make a multi-epitope protein vaccine. For this purpose, thesequences were retrieved from NCBI gene database and then antigenic determinant of ۴ proteins using IEDB,MHCpred, ProPred, RANKPEP, ABCpred, BCpreds, BepiPred, Ellipro servers were selected and a proteinstructure was designed using ۴ domains containing epitopes. After examining its antigenic and allergenicitypotential usingVaxiJen v۲.۰ server AllerTOP v۲.۰ server respectively, its three-dimensional structure wasdesigned by two servers, Robetta and I-TASSER and then it was docked with immune system receptors usingAutodock vina program embedded in the PyRx software. Finally, using the dynamic molecular method byGromacs package ۵.۱.۱, complexes and interactions were investigated and their interaction energies weremeasured. The results of the study showed that the designed structure has good relative stability and interactswell with its receptors and can be used as a vaccine candidate for further studies.

نویسندگان

Abbas Alibakhshi

Molecular Medicine Research Center, Hamadan University of Medical Sciences, Hamadan, Iran

Armina Alagheband Bahrami

Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran

Elmira Mohammadi

Core Research Facilities, Isfahan University of Medical Sciences, Isfahan, Iran- Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of MedicalSciences, Isfahan, Iran

Shahrzad Ahangarzadeh

Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences,Isfahan, Iran

Meysam Mobasheri

Department of Biotechnology, Faculty of Advanced Sciences and Technology, Tehran Islamic AzadUniversity of Medical Sciences, Tehran, Iran